For the Inventor, By the Inventor

Enter assignee name

Redwood City, CA, United States of America

Labrys Biologics, Inc.

USPTO Granted Patents = 11

CIPO Patents = 1

EPO Patents = 2

Forward Citations = 313

Loading Chart...

Loading Chart...

11 inventors (with patents filed for the assignee):

Kristian Todd Poulsen (11 out of 23 patents)

Joerg Zeller (11 out of 21 patents)

Arnon Rosenthal (9 out of 120 patents)

4. Jaume Pons (9 out of 54 patents)

5. Yasmina Noubia Abdiche (9 out of 25 patents)

6. Sierra Jones Collier (8 out of 13 patents)

7. David L Shelton (2 out of 44 patents)

8. Ariel Ates Pios (1 out of 2 patents)

9. Ian Machin (1 out of 4 patents)

10. Laura Corradini (1 out of 4 patents)

11. Sierra Lee Jones Collier (1 out of 1 patent)

12. David Louis Shelton (0 patent)

13. Laura Corradini (0 patent)

14. David Louis Shelton (0 patent)

11 patents: Sort by Forward Citations

1. 9365648 - Methods of using anti-CGRP antagonist antibodies (2016-06-14),

2. 9346881 - Antagonist antibodies directed against calcitonin gene-related peptide and methods using same (2016-05-24),

3. 9340614 - Antagonist antibodies directed against calcitonin gene-related peptide and methods using same (2016-05-17),

4. 9328168 - Methods of using anti-CGRP antagonist antibodies (2016-05-03),

5. 9328167 - Methods of treating chronic pain (2016-05-03),

6. 9266951 - Antagonist antibodies directed against calcitonin gene-related peptide and methods using same (2016-02-23),

7. 9115194 - Antagonist antibodies directed against calcitonin gene-related peptide and methods using same (2015-08-25),

8. 8734802 - Methods of treating vasomotor symptoms using antibodies (2014-05-27),

9. 8623366 - Methods for treating visceral pain by administering antagonist antibodies directed against calcitonin gene-related peptide (2014-01-07),

10. 8597649 - Antagonist antibodies directed against calcitonin gene-related peptide and methods using same (2013-12-03),

11. 8586045 - Methods of using anti-CGRP antagonist antibodies (2013-11-19),

Labrys Biologics, Inc. is a biotechnology company focused on the development of transformative therapies for migraine and other chronic pain disorders. Leveraging their expertise in antibody-based therapeutics, Labrys is committed to delivering novel treatment options that address the underlying mechanisms of these debilitating conditions.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

11 Patents

#135 in Redwood City, CA

#6,344 in California

#26,752 in US

#50,255 in the World

Redwood City, CA, United States of America

Labrys Biologics, Inc.

Forward Citations = 313

11 inventors:

Kristian Todd Poulsen (11 out of 23 patents)

Joerg Zeller (11 out of 21 patents)

Arnon Rosenthal (9 out of 120 patents)

4. Jaume Pons (9 out of 54 patents)

5. Yasmina Noubia Abdiche (9 out of 25 patents)

Please report any incorrect information to support@idiyas.com

Loading…